Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab

References (31)

1. 1 Hematological Problems in Pediatric Intensive Care [DOI]
2. 2 Non-Transgenic Mouse Models of Kidney Disease [DOI]
3. 3 Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome [DOI]
4. 4 Atypical Hemolytic–Uremic Syndrome [DOI]
5. 5 Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype [DOI]
6. 6 Atypical hemolytic uremic syndrome [DOI]
7. 7 Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome [DOI]
8. 8 Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies [DOI]
9. 9 Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome [DOI]
10. 10 Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria [DOI]
11. 11 STEC-HUS, atypical HUS and TTP are all diseases of complement activation [DOI]
12. 12 Dynamics of complement activation in aHUS and how to monitor eculizumab therapy [DOI]
13. 13 The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease [DOI]
14. 14 Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? [DOI]
15. 15 Homocysteine Triggers Mucosal Microvascular Activation in Inflammatory Bowel Disease [DOI]
16. 16 Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study [DOI]
17. 17 Cobalamin C defect associated with hemolytic-uremic syndrome [DOI]
18. 18 Cobalamin disorder Cbl‐C presenting with late‐onset thrombotic microangiopathy [DOI]
19. 19 Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13 [DOI]
20. 20 Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease [DOI]
21. 21 The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL ‐4 and IL ‐10 [DOI]
22. 22 Acute kidney injury in pregnancy: the thrombotic microangiopathies [DOI]
23. 23 Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles [DOI]
24. 24 The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease [DOI]
25. 25 Syndrome hémolytique et urémique lié à des anomalies du complément [DOI]
26. 26 Hemolytic Uremic Syndrome Following Bone Marrow Transplantation: A Case Report and Review of the Literature [DOI]
27. 27 Hyperhomocysteinemia and Related Genetic Polymorphisms Correlate with Ulcerative Colitis in Southeast China [DOI]
28. 28 Ischemic Colitis as a Manifestation of Thrombotic Microangiopathy Following Bone Marrow Transplantation [DOI]
29. 29 Acute colitis resembling ulcerative colitis in the hemolytic-uremic syndrome [DOI]
30. 30 Hemolytic-Uremic Syndrome Mimicking Ulcerative Colitis [DOI]
31. 31 The development of atypical hemolytic uremic syndrome is not influenced by thrombophilia susceptibility factors [DOI]

Cited by 28

Showing 14 of 28 known citations — external sources report more than can currently be individually listed.

Related research

• The Influence of Risk Factors on Acute Kidney Injury in Rhabdomyolysis Patients: A Comprehensive Review — shares topic coverage
• Feasibility and Hemodynamic Tolerability of Sustained Low- Efficiency Dialysis in Critically Ill Patients with Acute Kidney Injury — shares topic coverage
• Spectrum and Outcomes in Patients with Skin and Subcutaneous Tissue Infections and Severe Renal Dysfunction — shares topic coverage
• Evaluation of Kidney Injury Molecule-1, Creatinine and Urea Levels in Alcohol, Cigarettes, and Polyherbal Medicines (Agbo) Consumers in Nnewi Metropolis, Nigeria — shares topic coverage
• Pathways of Renal Involvement in COVID-19 Infection — shares topic coverage